• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM Back to Search Results
Catalog Number 142122-01
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ischemia (1942); Pain (1994); Restenosis (4576)
Event Date 12/14/2023
Event Type  Injury  
Manufacturer Narrative
This is related to mdr report 3011632150-2023-00151.There was no reported device malfunction and the device was not returned for analysis.A review has been performed of the manufacturing certificate of conformance associated with this lot.There were no non-conformances or deviations which could be associated with this event.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effects of restenosis leading to intervention and ischemia/pain are listed in the biomimics 3d instructions for use and are a known patient effect of peripheral stenting procedures.There is no indication of a product quality issue with respect to the design, manufacture or labelling of the device.If further information regarding this event becomes available, a follow-up report will be submitted.
 
Event Description
This is related to mdr report 3011632150-2023-00151.The patient was treated as part of the mimics 3d usa post-market observational study.On (b)(6) 2021, the patient was implanted with two biomimics 3d (bm3d) stents in the right leg, a 5.0 x 150 mm stent which was used to treat a restenotic lesion in the superficial femoral artery (sfa) proximal third to sfa middle third and a 5.0 x 60 mm stent (the subject of this report) which was used to treat a denovo lesion in the sfa middle third to sfa distal third.An antegrade approach was used and the lesion was prepared using pre-dilation with a percutaneous transluminal angioplasty (pta) balloon.The treated segment was post-dilated with pta.The site identified a restenosis of treated segment (target lesion) event on (b)(6) 2023.It was reported as possibly related to the device and not related to the procedure.It was target lesion related.The patient came into the office on (b)(6) 2023 for her 24-month study visit complaining of ischemic rest pain in her right leg (target leg).An ultrasound showed an occlusion in the distal part of her stent.She had an angiogram on her right leg on (b)(6) 2023 which confirmed an occlusion in the distal third of the stent (distal sfa and proximal popliteal).This was treated on (b)(6) 2023 with drug coated balloon / drug eluting balloon (dcb/deb), plain old balloon angioplasty (poba) / pta / standard balloon angioplasty and laser/atherectomy.Further imaging showed some evidence of stenoses at the upper portion of the stent and a small segment of the proximal sfa which was treated with angioplasty.The intervention was reported as a target lesion/vessel revascularisation (tlr/tvr) that involved the sfa proximal third to proximal popliteal artery.The outcome was reported as resolved/recovered.A completion arteriogram showed full resolution of the stenoses with brisk flow and no evidence of complications.The devices remain implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOMIMICS 3D VASCULAR STENT SYSTEM
Type of Device
BIOMIMICS 3D VASCULAR STENT SYSTEM
Manufacturer (Section D)
VERYAN MEDICAL LTD
block 5
parkmore east business park
galway, H91 V 0TX
EI  H91 V0TX
Manufacturer Contact
alan mcdonagh
block 5
parkmore east business park
galway, H91 V-0TX
EI   H91 V0TX
MDR Report Key18533217
MDR Text Key333088135
Report Number3011632150-2023-00152
Device Sequence Number1
Product Code NIP
UDI-Device Identifier05391526850381
UDI-Public(01)05391526850381(17)220813(11)210112(10)0000066597
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 01/18/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/18/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/13/2022
Device Catalogue Number142122-01
Device Lot Number0000066597
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/12/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
APIXABAN
Patient Outcome(s) Required Intervention;
Patient Age87 YR
Patient SexFemale
Patient Weight44 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-